Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
월요일, 8월 24

Indaptus Therapeutics Inc

INDPNASDAQ
Trade with Public
Trade with Public
$1.14
-0.15-11.63%
마지막 업데이트: Aug 24, 2:16 PM
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교주식 보고서

Indaptus Therapeutics Financials

Indaptus Therapeutics (INDP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Indaptus Therapeutics Q2 EPS $(0.02) Beats $(1.57) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(1.57) by 98.73 percent. This is a 99.78 percent increase over losses of $(9.09) per share
Benzinga Newsdesk

Earnings Scheduled For May 15, 2026

Benzinga Insights

PRO
Indaptus Therapeutics Q1 EPS $(0.23) Beats $(1.87) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(1.87) by 87.7 percent. This is a 97.43 percent increase over losses of $(8.96) per share
Benzinga Newsdesk

PRO
Indaptus Therapeutics Q3 EPS $(2.98) Beats $(4.17) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(2.98) per share which beat the analyst consensus estimate of $(4.17) by 28.54 percent. This is a 67.04 percent increase over losses of $(9.04) per share
Benzinga Newsdesk

PRO
Indaptus Therapeutics Q2 EPS $(9.09) Beats $(9.24) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(9.09) per share which beat the analyst consensus estimate of $(9.24) by 1.62 percent. This is a 30.93 percent increase over losses of $(13.16) per share
Benzinga Newsdesk

PRO
Indaptus Therapeutics Q1 EPS $(0.32) Misses $(0.18) Estimate

Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.18) by 77.78 percent. This is a 28.89 percent increase over losses of $(0.45) per
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved